Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - Seattle-based Infectious Disease Research Institute announced today it has received a multi-million dollar grant from the Bill and Melinda Gates Foundation to use "chemical genomics" medium- and high-throughput screening approaches to identify candidate targets against tuberculosis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.